# Neurodevelopmental disorders in children: the role of MRI in early detection and intervention planning

**Authors:** Chen Hua, Xue-Ling Wang, Hui Sheng

PMC · DOI: 10.3389/fnins.2026.1758568 · Frontiers in Neuroscience · 2026-03-11

## TL;DR

MRI helps detect brain development issues in children early, allowing for timely interventions to improve outcomes.

## Contribution

The paper reviews how MRI techniques can serve as biomarkers for early detection of neurodevelopmental disorders.

## Key findings

- MRI can detect subtle brain abnormalities linked to disorders like autism and ADHD.
- Combining MRI with machine learning and genomics improves early diagnosis and risk assessment.
- Different MRI modalities reveal distinct neurochemical and structural changes in NDDs.

## Abstract

A group of diseases caused by disruptions in early brain maturation is collectively known as neurodevelopmental disorders (NDDs). These are characterized by persistent deficits in cognition, behavior, social or motor functioning. The heightened neuroplasticity could be modulated by appropriate intervention during early childhood. Therefore, early detection of NDDs is critical to improve long term developmental outcomes. However, conventional and behavioral studies are insufficient to detect the subtle early alterations, causing diagnostic delays. So, for NDDs, magnetic resonance imaging (MRI) serves as a critical tool for elucidating neurochemical, microstructural, and functional abnormalities. It has the potential to detect the alterations associated with different NDDs including autism spectrum disorder, attention deficit/hyperactivity disorder, genetic/metabolic syndromes, cerebral palsy, and developmental delay. Multiple modalities of MRI such as diffusion imaging, quantitative MRI, resting state functional MRI, and spectroscopy are applied for these disorders. Collectively, these MRI modalities, machine learning and integrative genomic approaches offer promising biomarkers for early detection and risk stratification of NDDs. This review highlights the current evidence on the bases of pediatric MRI approaches, early predictive biomarkers, disease specific findings, and translational applications.

## Linked entities

- **Diseases:** autism spectrum disorder (MONDO:0005258), attention deficit/hyperactivity disorder (MONDO:0007743), cerebral palsy (MONDO:0006497)

## Full-text entities

- **Diseases:** NDDs (MESH:D002658), syndromes (MESH:D013577), attention deficit/hyperactivity disorder (MESH:D001289), genetic (MESH:D030342), autism spectrum disorder (MESH:D000067877), cerebral palsy (MESH:D002547)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13013303/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13013303/full.md

## References

159 references — full list in the complete paper: https://tomesphere.com/paper/PMC13013303/full.md

---
Source: https://tomesphere.com/paper/PMC13013303